Filtered By:
Source: Cancer Chemotherapy and Pharmacology
Cancer: Rhabdomyosarcoma
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Targeting ALK in pediatric RMS does not induce antitumor activity in vivo
ConclusionsWhile ALK appears to be a relevant target in RMS in vitro, targeting this kinase in vivo yields no therapeutic efficacy, warranting extreme caution when considering the use of these agents in pediatric RMS patients.
Source: Cancer Chemotherapy and Pharmacology - May 31, 2018 Category: Cancer & Oncology Source Type: research
